most of the small cap stuff I'm itching to buy didn't budge today. In fact, some of it was up a little! I mainly watch for growth stocks which are trading at bargain prices. It takes a lot of patience.
with respect to MRK, it wasn't too long ago that 27 PE was reserved for "growth" stocks. MRK mostly purchases their pipeline these days. You've got to look at who they are investing their dollars in to get the growth aspect. IMO, that makes MRK no different than a utility company. They supply a basic need, in pharmaceutical products, to an aging population. They have accountants work out costs and statisticians work out investment probabilities. Anyway, they just aren't cutting edge. Their pipeline is on the weak side even compared with other big pharma companies.
I looked at PFE, BMY, AHP, WLB, MRK, AZN, GLX, NVTSY. AZN and GLX look the best, I think (in that order). |